Accenture and Bristol-Myers Squibb have launched a joint center for pharmacovigilance in Chennai, India. The new center will be operated by more than 140 Accenture employees and will undertake the processing and coding of adverse event data and the generation of regulatory reports on safety as well as physician medical review of adverse events. Pharmacovigilance, safety data monitoring to ensure optimal use of medicines, entails the capture, assessment, and reporting of potential side effec...